CION Ameerpet
Kidney cancer · Hereditary & genetics
VHL beyond the kidney — the eye, brain, adrenal glands and pancreas
Most people meet von Hippel-Lindau disease through the kidney, and then discover it is not really a kidney condition at all. The VHL gene fault sits in every cell of the body, so the organs it can affect stretch from the retina at the back of the eye to the brain and spinal cord, the adrenal glands, the pancreas and the inner ear. This page walks through the VHL affected organs one at a time — what can appear in each, what it usually turns out to be, and why a surveillance schedule is the whole point.
- VHL is a whole-body condition — one gene, several organs, and no two people affected in exactly the same combination.
- Most of what is found is benign — hemangioblastomas, adrenal tumours and pancreatic cysts in VHL are usually not cancer.
- Surveillance is arranged in-house — genetic counselling, MRI, CT, ultrasound and hormone bloods, on a schedule set by the treating team.
- 45-minute consultation, free — bring your reports and your family history and leave with a plan rather than a list of worries.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The short answer
Why one gene affects so many different organs
Because the fault is everywhere, from the beginning. In von Hippel-Lindau disease the change sits in a single gene that a person carries from birth in every cell of the body — not in one organ that went wrong. So the question is never "why has it spread to my eye or my brain", because nothing has spread. Each growth starts independently, in its own place, from cells that were all carrying the same disadvantage the whole time.
What that gene normally does. The VHL gene is part of the machinery a cell uses to sense how much oxygen it is getting. When it works, it keeps the signal that says build more blood vessels switched off unless the cell genuinely needs it. When it does not work, that signal stays on. Tissues that are naturally rich in blood vessels — the retina, the lining of the brain and spinal cord, the adrenal glands, the pancreas, the kidney — are the ones where an over-active blood-vessel signal shows up as a growth. That is the whole logic of which organs are on the surveillance list and which are not.
Benign is the usual answer, not the exception. Several of the classic VHL findings are not cancer at all. A hemangioblastoma in the eye or the nervous system is benign and does not spread. Adrenal tumours in VHL are usually benign. Pancreatic cysts are benign. What these growths do instead is take up space, press on something delicate, or — in the case of the adrenal gland — release hormones that the body was not asking for. That is a different kind of problem from cancer, and it is managed differently.
The kidney is one organ on the list, not the headline. VHL can produce kidney cysts and clear cell kidney tumours, and that part of the story has its own page: Von Hippel-Lindau (VHL) disease and kidney cancer covers how the kidney is watched and what happens when something is found. This page is about everything else. For the disease itself, independent of VHL, start with our kidney cancer guide.
Nothing here is a diagnosis, and reading about an organ does not mean it is affected in you. Many people with VHL have growths in only some of the organs described below, and some findings never need treating. If VHL has been confirmed in you or in a relative, book a free consultation and have the surveillance plan built properly instead of assembling one from web pages.
Did you know?
The organ that most often brings someone to a VHL diagnosis is not the kidney at all — it is the eye. A retinal hemangioblastoma can be spotted during a routine dilated eye examination, long before anything is felt anywhere else, which is why an eye check is part of the schedule from an early age and why an ophthalmologist is sometimes the first person to suggest the diagnosis.
Organ by organ
The VHL affected organs, and what can appear in each
Read this as a map of what a surveillance schedule is looking for — not as a list of what will happen to you. Involvement varies enormously between people, and often runs in a recognisable pattern within one family.
Eye · retina
Retinal hemangioblastoma
A benign tangle of small blood vessels on the retina. It does not spread, and a small one may cause nothing at all. Left unwatched, it can leak fluid, pull on the retina or affect sight, and a lesion sitting near the optic nerve is harder to treat than one at the periphery — which is precisely why a dilated eye examination is on the schedule from an early age. Treatment, where it is needed, is delivered by specialist ophthalmology partners we refer to and coordinate with.
Brain · spinal cord
Central nervous system hemangioblastoma
The same benign blood-vessel growth, in the cerebellum at the back of the brain, the brainstem, or the spinal cord. Again, not cancer and not a spread. Symptoms, when they come, are mechanical — headache, unsteadiness, poor coordination, or numbness and weakness if the cord is involved — and are often caused by an associated fluid-filled cavity rather than the growth itself. Many are simply watched on MRI. Where an operation is needed, it is coordinated with specialist neurosurgical partners. Our brain tumour guide explains how growths inside the skull are assessed generally.
Adrenal glands
Pheochromocytoma
A tumour of the adrenal gland, which sits directly on top of the kidney. In VHL it is usually benign, and it can involve both glands. The reason it is taken seriously is hormonal: it can release fight-or-flight hormones in bursts, causing episodes of pounding headache, sweating, palpitations, anxiety and raised blood pressure — and those surges are genuinely risky if nobody knows about them before an operation or a pregnancy. Screening is with straightforward blood and urine tests, done in-house. Surgery, when required, is coordinated with specialist endocrine surgery partners. See our adrenal cancer guide for how adrenal tumours are assessed in general.
Pancreas
Cysts and neuroendocrine tumours
Two quite separate findings. Simple pancreatic cysts are common in VHL, are benign, are often multiple, and usually need nothing more than a note on the report. Pancreatic neuroendocrine tumours are a different thing: many behave quietly and are watched, with decisions driven by size, by growth between scans and by imaging features rather than by their existence. A cyst is not a cancer. Where an operation is warranted, it is coordinated with specialist surgical partners. Our pancreatic cancer guide covers pancreatic disease more broadly.
Inner ear
Endolymphatic sac tumour
The organ people forget. This is a slow-growing tumour of the inner ear that can cause hearing loss, ringing in the ear, vertigo or unsteadiness — symptoms easy to blame on something ordinary. It is worth knowing about because hearing lost before it is treated does not necessarily come back, so new or one-sided hearing symptoms in someone with VHL are a reason to be seen rather than to wait. A hearing assessment and dedicated inner-ear imaging are the usual route.
Kidney
Kidney cysts and clear cell tumours
The kidney is on the list too, and in VHL it is normal for cysts and tumours to be multiple and to affect both kidneys over a lifetime. The whole aim of scheduled imaging is to find lesions while they are small, which is when there are the most options and when as much working kidney as possible can be preserved. Kidney surgery and ablation are delivered at specialist partner centres, which CION coordinates with uro-oncology and interventional radiology. The detail lives on our VHL and kidney cancer page.
Reproductive tract
Epididymal and broad ligament cystadenoma
Benign cystic growths of the epididymis in men and, less commonly, of the broad ligament in women. They are not cancer and frequently need no treatment. They are listed here mainly so that a scan report using one of these words does not read as bad news, and because in a man with no other known VHL feature, finding them on both sides is one of the clues that can prompt a specialist to ask about the rest of the family.
Notice what is not on this list. VHL is not a reason to worry about every organ in the body, and a finding in an organ that is not on this list is far more likely to have an ordinary explanation than to be part of the syndrome. That judgement is worth making with a specialist rather than alone.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Seven organs, one schedule, one team holding it
A 45-minute consultation to review what has been scanned, what is missing, and who needs to be looking at each organ from here.
How it is actually run
How lifelong VHL surveillance is organised
The difference between VHL managed well and VHL managed badly is almost never the treatment. It is whether somebody owns the schedule. Here is what that looks like in practice.
Confirm the diagnosis, and confirm it properly
VHL is diagnosed on genetic testing, and testing follows genetic counselling rather than replacing it. That conversation is led in-house by medical oncology at CION: the family history is drawn out first, the implications for relatives are explained, and only then is testing arranged. NCCN guidance recommends genetic risk evaluation where kidney cancer is diagnosed at a young age, affects both kidneys or several sites, or where close relatives have been affected — which is how many families first arrive at a VHL diagnosis.
Build one schedule that covers every organ
Not a scan when something hurts. A written plan covering the eye examination, MRI of the brain and spine, abdominal imaging for the kidneys, adrenal glands and pancreas, blood and urine tests for adrenal hormone excess, and a hearing check. Which tests start at which age, and how often each repeats, is set by the treating team and varies with age and with what has already been found. The imaging, the bloods and the review appointments are arranged in-house.
Watch first, treat when watching stops being enough
A great deal of what surveillance finds in VHL is watched rather than removed — small nervous-system hemangioblastomas causing no symptoms, pancreatic cysts, small kidney lesions. What triggers action is change: growth between scans, pressure on something that matters, hormone release, or a lesion reaching a size where the options narrow. Being watched is not being neglected; it is what allows treatment to be timed rather than rushed.
Bring in the right specialist for the right organ
No single doctor operates on the retina, the brainstem, the adrenal gland, the pancreas and the kidney. Eye treatment, neurosurgery, adrenal and pancreatic surgery, kidney surgery and ablation are all delivered at specialist partner centres, which CION coordinates with ophthalmology, neurosurgery, endocrine surgery, uro-oncology and interventional radiology. Advanced staging imaging such as PET-CT is arranged the same way. What stays with your CION team is the medical oncology review, the schedule and the thread connecting all of it.
Test the family, and then watch the family
VHL is autosomal dominant: each child of an affected parent has a one-in-two chance of carrying the same gene fault, sons and daughters equally. Once the fault is identified in one person, relatives can be tested for that specific change — and those who carry it enter surveillance instead of waiting for symptoms, while those who do not are released from the worry entirely. That second outcome is one of the most useful things a genetic diagnosis produces.
Do not sit on a new symptom between scans
A schedule is not a guarantee that nothing happens in the gaps. New or worsening vision changes, headache with unsteadiness, numbness or weakness, episodes of pounding headache with sweating and palpitations, new one-sided hearing loss or vertigo, and blood in the urine even once are all reasons to be seen now rather than at the next appointment. If a kidney lesion is what has been found, kidney cancer treatment in Hyderabad sets out what happens next.
This page deliberately puts no numbers on how likely each organ is to be involved, or at what age. Published figures describe groups, not individuals, and quoting one at you without knowing your gene change, your family and your scans so far would be misleading rather than reassuring. A consultation can give you the version that applies to you.
You should not be coordinating this yourself
One team can hold the whole VHL schedule
Bring your reports and what you know about the family. You will leave with a plan covering every organ, and a clear answer on who needs to see what and when.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
VHL beyond the kidney - your questions answered
Which organs does VHL affect besides the kidney?
The organs a VHL team watches are the retina at the back of the eye, the brain and spinal cord, the adrenal glands sitting above the kidneys, the pancreas, the inner ear, and the reproductive tract, alongside the kidneys themselves. Not everyone with VHL develops growths in all of them, and many people are affected in only some. Which organs are involved often follows a pattern within a family, which is one reason a confirmed diagnosis is so useful for relatives. Much of what surveillance finds is benign, and a good deal of it never needs treatment at all, only watching.
What is a hemangioblastoma, and where does it grow?
A hemangioblastoma is a benign growth made largely of small blood vessels. In VHL it appears in two places: the retina at the back of the eye, and the central nervous system, most often the cerebellum at the back of the brain, the brainstem, or the spinal cord. It is not cancer and it does not spread. The trouble it causes is mechanical: it can leak fluid, press on the tissue beside it, or, in the eye, threaten sight. That is why these are watched with planned MRI and eye examination rather than left until symptoms appear.
What is a pheochromocytoma, and why does VHL cause it?
A pheochromocytoma is a tumour of the adrenal gland, which sits on top of the kidney and makes the hormones that drive the body's fight-or-flight response. When such a tumour releases those hormones in bursts, it can cause episodes of pounding headache, sweating, palpitations, anxiety and raised blood pressure. In VHL these tumours are usually benign, and they can affect both adrenal glands. They matter because the hormone surges are dangerous if nobody knows about them, particularly during an operation or a pregnancy, so they are screened for with straightforward blood and urine tests before they cause trouble.
Do the pancreatic changes in VHL turn into cancer?
Usually not. The commonest pancreatic finding in VHL is simple cysts, which are benign, often multiple, and generally need nothing beyond being noted on the scan. Separately, VHL can produce pancreatic neuroendocrine tumours, which are a different kind of growth. Many of these behave quietly and are watched rather than removed. Decisions about them turn on size, on growth over time and on imaging features, rather than on their presence alone, which is exactly why surveillance scans are repeated on a schedule. A cyst reported on a pancreas scan is not a cancer diagnosis and should not be read as one.
How often does someone with VHL need scans and check-ups?
Surveillance in VHL is lifelong and runs to a schedule rather than to symptoms. It usually combines an eye examination, MRI of the brain and spine, imaging of the abdomen to cover the kidneys, adrenal glands and pancreas, blood and urine tests for adrenal hormone excess, and a hearing check. The exact intervals, and the age at which each test starts, are set by the treating team and change with age and with what has already been found, so no single timetable fits everyone. At CION the imaging, the bloods and the review appointments are arranged in-house, and the schedule is revisited at every visit.
If I have VHL, will my children have it?
VHL is passed on in an autosomal dominant pattern, which means each child of an affected parent has a one-in-two chance of inheriting the gene fault, and it affects sons and daughters equally. Inheriting the fault is not the same as being ill: it means the person should enter planned surveillance so that anything that does develop is found early. Because a result has consequences for the whole family, testing is always preceded by genetic counselling, which is led in-house by medical oncology at CION and covers who to test, at what age, and what the answer would actually change.
This page is general information about von Hippel-Lindau disease, not a diagnosis and not a personal surveillance plan. Only a doctor who has reviewed your genetic result, your scans and your family history can tell you which organs need watching in your case, and how often.